mWIG40/ PL9999999912
PL9999999912| 23/08/2024 17:09:45 | Chg. -12.3 | Open | High | Low | Previous Close |
|---|---|---|---|---|---|
| 6,197.8PLN | -0.20% | 6,210.8 | 6,223.2 | 6,182.5 | 6,210.1 |
GlobeNewswire
11/12/2023
Ryvu Therapeutics Presents Data on RVU120 at the 2023 American Society of Hematology (ASH) Annual Me...
GlobeNewswire
07/12/2023
Ryvu Therapeutics Presents Data on RVU120 at the San Antonio Breast Cancer Symposium 2023
GlobeNewswire
29/11/2023
Ryvu Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire
23/10/2023
Ryvu Therapeutics Provides an Update on the Progress of RVU120 Phase I Studies in Patients with Soli...
GlobeNewswire
04/10/2023
Ryvu Therapeutics to Present Preclinical Data on PRMT5 and its Synthetic Lethality Platform at the 2...
GlobeNewswire
13/09/2023
Ryvu Therapeutics Reports 2023 Half-Year Financial Results and Provides Corporate Update
